"Designing Growth Strategies is in our DNA"

Hereditary Testing Market Size, Share, and Analysis, By Type (Cancer Tests, Prenatal Screening Tests, Rare & Inherited Disease Screening Tests, Others ), By Technology (Cytogenetic, Biochemical, and Molecular), By End User (Hospitals & Specialty Clinics, Diagnostic centers, and Others), and Regional Forecast, 2024-2032

Region :Global | Report ID: FBI107158 | Status : Ongoing

 

KEY MARKET INSIGHTS

Hereditary testing is a medical test that detects genetic, chromosomal, or protein alterations, with an aim to confirm or rule out a specific genetic disease, and indicate a person’s risk of developing or passing on a genetic disorder. The main drivers for the hereditary testing market are the steady rise in demand for genetic testing and the rising focus on reproductive genetic health among the population worldwide. An increasing number of genetic screenings of newborns and prenatal is also helping to drive the market's revenue globally.


Moreover, an increase in the prevalence of inherited diseases, growing public awareness of the harmful implications of genetic diseases, new breakthroughs in genetic analysis, and the emergence of rare diseases are the key factors driving the hereditary testing market.


  • For instance, in July 2022, according to a report by the International Journal of Neonatal Screening, about 15,000 newborns are evaluated annually in the U.S. for genetic and metabolic diseases.

  • According to an article published by the National Academy of Science in January 2020, through computing genotype data from six significant world populations in 187 Inherited Retinal Disease (IRD)-associated genes, detected 10,044 mutations and estimated that 2.7 billion individuals worldwide are carriers of an IRD disease-causing mutation, whereas 5.5 million are expected to be affected.


Impact of COVID-19 on the Hereditary Testing Market


The COVID-19 pandemic negatively impacted the hereditary testing market in 2020 owing to the imposed lockdowns and the globally compelled social isolation by the World Health Organization (WHO). Moreover, the pandemic affected the number of genetic counselors to meet with clients in person, the unavailability of doctors to assist patients, and the laboratory’s inability to perform the tests. Further, as regulatory bodies such as the Centers for Medicaid Services (CMS) do not consider genetic counselors as healthcare practitioners, they were prohibited from working during government shutdowns.


  • For instance, according to a research article published in the Journal of Medical Genetics 2020, a hindrance was reported due to COVID-19 in accessing genetic testing blood draws, as a result of which genetic testing was tremendously impacted, wherein a reduction in genetic testing from 97.7% to 74.1% was observed during the pandemic.



  • In May 2020, according to the Centers for Disease Control and Prevention (CDC), most clinics and hospitals in the U.S. restricted in-person delivery of non-essential healthcare services, including genetic counseling, due to the unavailability of counselors for attending patients to minimize coronavirus transmission.


Key Insights



  • Prevalence of Cancer, By Key Countries, 2021

  • Impact of COVID-19 on Hereditary Testing Market

  • New Product Launches

  • Technological Advancements in Hereditary Testing

  • Key Industry Developments Mergers, Acquisitions, and Collaborations


Analysis by Type


In 2021, the hereditary cancer testing segment accounts for a larger share of the global hereditary testing market. The growth is attributed to the increasing number of new products and services available for detecting hereditary cancer. Moreover, the rising focus of key companies on new technological developments and commercial strategies to strengthen their position in this field are likely to drive the segment growth.


  • For instance, in March 2022, Illumina Inc., launched a cancer test in Europe that checks for a wide range of tumor genes in one tissue sample, potentially helping patients with rare diseases to be matched with treatment options.


Regional Analysis


To gain extensive insights into the market, Request for Customization


North America accounts for a larger share of the global hereditary testing market due to the rising incidence of genetic disorders and increasing commercial acceptance of hereditary testing. Also, numerous key companies providing genetic disease testing, the widespread use of modern therapies, and changing regulations in the guidelines by the government to maintain the integrity of hereditary testing screening are likely to drive the regional growth of the market.


  • According to the National Institutes of Health (NIH), more than 30.0 million individuals in the U.S. suffer from around 7,000 genetic disorders.


Key Players Covered


The report will include the profiles of key players such as Illumina, Inc., Genes2Me, Myriad Genetics, Inc., Natera, Inc., Quest Diagnostics Incorporated, CENTOGENE N.V., Thermo Fisher Scientific, Inc., Twist Bioscience, Fulgent Genetics, Inc., MedGenome, and others.

Segmentation


















By Type


By Technology


By End User


By Geography



  • Cancer Tests

  • Rare & Inherited Disease Screening Tests

  • Prenatal Screening Tests

  • Others




  • Cytogenetic

  • Biochemical

  • Molecular




  • Hospitals & Specialty Clinics

  • Diagnostic Centers

  • Others




  • North America (U.S. and Canada)

  • Europe (U.K., Germany, France, Spain, Italy, and the Rest of Europe)

  • Asia Pacific (India, Japan, China, Australia, and the Rest of APAC)

  • Latin America (Brazil, Mexico, and Rest of Latin America) 

  • Middle East & Africa (GCC, South Africa, and the Rest of MEA)



Key Industry Developments



  • In December 2021, Helio Health and its commercial partner, Fulgent Genetics, Inc., announced the commercial launch of HelioLiver. This multi-analyte blood test incorporates cell-free DNA methylation patterns and serum protein markers for the early detection of hepatocellular carcinoma (HCC), the most common form of liver cancer.

  • In November 2021, MedGenome Labs, a leading genetic diagnostics and research company, acquired Trident Diagnostics & Healthcare Pvt. Ltd., a diagnostics and radiology healthcare center based in Bengaluru, India. This partnership will help MedGenome make genetic testing accessible to clinicians, patients, and consumers across the country.

  • In August 2021, Fulgent Genetics, Inc., a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, announced its acquisition with CSI Laboratories to expand its presence in somatic molecular diagnostics and cancer testing.





  • Ongoing
  • 2023
  • 2019-2022

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Amgen
Siemens Healthineers
Ansell
Jubilant
Roche

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X